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Bacillus subtilis is a model organism and the entire genome has been sequenced.  
However, there is an incomplete understanding of the metabolic pathways that are 
encoded within the genome.  A long-term goal of the Reddick research group is to gain a 
more complete understanding of the mmg operon.  The overall objective is to complete 
the syntheses of 2-methylisocitrate and develop a stereoselective synthesis of 2-
methylcitrate.  The central hypotheses of these projects are that MmgF cleaves one of the 
enantiomers of 2-methylisocitrate to produce succinate and pyruvate, and MmgD 2-
methylcitrate synthase produces heterochiral ((2S-3R) or (2R,3S))-2-methylcitrate.  The 
completed syntheses will facilitate new investigations furthering the understanding of the 
mother cell metabolic (mmg) operon.  The synthesis of (2RS, 3RS)-2-methylisocitrate has 
been completed with modified literature methods, and the synthesis of (2RS, 3SR)-2-
methylisocitrate has required multiple modifications in order to make the synthesis 
reproducible.  Previous graduate students either were unable to finish the synthesis or 
experienced reproducibility problems with this synthesis.  The stereoselective synthesis 
of 2-methylcitrate has been designed and the initial steps in the synthesis have begun.  
The progress made in these two projects will allow the Reddick research group to reach 
its long-term goal of obtaining more information and a better understanding of Bacillus 
subtilis and the mmg operon.
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CHAPTER I 
INTRODUCTION 
1.1 Review of Literature 
1.1.1 Overview and Applications of Bacillus subtilis 
Bacillus subtilis is an aerobic, rod shaped, Gram positive bacterium1 that is 
industrially relevant, and used as a model organism.  This can be attributed to the entire 
genome being sequenced1 and its ability to undergo genetic modifications.2  B. subtilis is 
also used to study the bacterial sporulation process.3  B. subtilis inhabits different 
environmental conditions such as soil, within the gastrointestinal tract of specific 
animals,4 and among decomposing organic matter.4  B. subtilis is considered to be an 
aerobic bacterium, but it has been shown to function as a facultative anaerobic in the 
presence of nitrates.5 
The genome of B. subtilis consist of over 4 million base pairs which encode for 
4,100 proteins.1   When used in industry the genetic sequence can be modified for the 
production of polyhydroxyalkanoates,6 biosurfactants,7 hyaluronic acid,8 and bacitracin.9 
B. subtilis is also used in agriculture to inoculate soil.10   The industrial efficacy of B. 
subtilis could be increased by obtaining a better understanding of the sporulation process. 
1.1.2 Summary of Sporulation 
B. subtilis and other rod-shaped bacteria undergo sporulation when environmental 
conditions are less than favorable for survival.3,6,11  Some of these conditions include, but 
2 
are not limited to, a lack of oxygen, glucose, nitrogen, and phosphorus.  The sporulation 
process is initiated by the spo genes and is regulated by transcription factors located with 
the developing spore and the mother cell.3,11 
During periods of nutritional or environmental stress, B. subtilis will undergo an 
asymmetric division.3,11  The bacterium will undergo several distinct morphological and 
physiological changes.  During stage I, the bacterium experiences environmental stress 
and a cleavage furrow forms at one end of the cell.  Cytokinesis occurs during stage II 
which creates the septum and forms the pre-spore and the mother cell.  Stages III, IV, and 
V, involve the mother cell engulfing the spore, formation of the cell membrane, wall, and 
cortex, and final the spore coat.  Upon maturation of the endospore cell lysis will occur 
and the free spore will be released.  When the environmental conditions improve the 
spore can undergo germination to reenter the vegetative state.3 
Before cytokinesis occurs in the early stages, the DNA of the bacterium is 
duplicated and both the pre-spore and mother cell receive a complete copy.  
Differentiation of the cells is controlled by the expression and activation of different 
genes.  RNA polymerases contain variable sigma (σ) factors which act as transcription 
factors and control the transcription of genes.3,11  The σ factors direct the RNA 
polymerases to the promoter region of specific genes.3,11  This ensures that specific genes 
are expressed and others are not. 
During the vegetative stage σA is the major transcription factor and works 
simultaneously with σH, the minor transcription factor.  The formation of the mother cell 
and pre-spore is directed by the activity of σE and σF, respectively.  The maturation and 
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formation of the spore’s cell membrane, wall, and cortex, is regulated by σG.  During late 
stage sporulation, genetic transcription in the mother cell is directed by σH.  The activity 
of the transcription factors produces different proteins in the two chambers.  Through the 
production of different proteins and the activation of different genes the spore and mother 
cell take on their own specialized functions and became differentiated from each other.   
There are several other gene clusters and RNA transcription factors involved in 
sporulation.  As a result of the discussed sigma factors along with the activation of other 
genes a spore will be formed and the mother cell will undergo lysis to release the spore.  
The spore created in the process has the ability to survive harsh environmental conditions 
for thousands of years.  Once the environmental conditions improve the spore will 
undergo germination and enter the vegetative stage continuing the normal life cycle of 
growth and replication.   
1.1.3 Genetic Regulation of the Mother Metabolic Gene Operon 
During the early stage of sporulation, σE is active in the mother cell and is the 
required σ factor for the mother metabolic gene (mmg) operon.  This operon has been 
shown by the Reddick Lab to encode for β-oxidation of fatty acids and the metabolism of 
propionyl CoA via the methylcitric acid cycle.  The mmg operon consists of a sequence 
of six genes, mmgABCDE and yqiQ (now named mmgF).  The first three genes in the 
sequence (mmgABC with additional activity from yhaR) encode for the metabolism of 
short chain fatty acids by the β-oxidation pathway.  The rest of the genes in the operon, 
with assistance from CitB (a known aconitase enzyme in B. subtilis), encodes for the 
methylcitric acid cycle.12 
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1.1.4  Activity of the mmg Operon and β-oxidation 
During β-oxidation, fatty acyl CoAs are shortened by a two carbon unit through a 
series of four reactions.  First the acyl CoA 1 is oxidized to enoyl CoA 2 (an acyl-CoA 
dehydrogenase, MmgC), then hydrated to form β-hydroxyacyl CoA 3 (an enoyl-CoA 
hydratase, YhaR).  A second oxidation produces β-ketoacyl CoA 4 (β-ketoacyl CoA 
dehydrogenase, MmgB), which is then cleaved to produce acetyl CoA 5 and an n-2 acyl 
CoA (thiolase, MmgA).  Once the fatty acid has been completely metabolized the final 
cleavage will produce two molecules of acetyl CoA.7  This β-oxidative pathway is 
depicted in Figure 1. 
 
 
In some bacterial species, such as B. subtilis, the omega-3 position of the fatty 
acid chain has the possibility to be methylated.  When this occurs the fatty acid is then 
referred to as an anteiso fatty acid.  In B. subtilis this ω-3 methyl branch is present in 
greater than 80 % of the fatty acids.13,14  In other species the methylation depends on 
environmental conditions and often happens 40 to 60 % of the time.14  This affects the 
outcome of β-oxidation.  The anteiso fatty acid will produce propionyl CoA 6 and acetyl 
 
Figure 1. β-Oxidation of Fatty Acid Acyl-CoA’s.  β-oxidation of fatty acyl-CoA’s 
occurs in four basic reactions that are repeated until the final step produces two 
acetyl-CoA molecules.  In Bacillus subtilis the mmg operon encodes for fatty acid 
degradation.  The genes mmgC, mmgB, and mmgA, with assistance from yhaR, are 
responsible for this process. 
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CoA 5 in the final step of the degradative pathway.  This process is outlined in Figure 2 
with the enzymes MmgABC and YhaR.  Both acetyl-CoA 5 and propionyl-CoA 6 are 
condensed with oxaloacetate 7 to produce citrate 8 and 2-methylcitrate 9, respectively.  
Citrate is then metabolized in the citric acid cycle, but 2-methylcitrate is utilized in the 
methylcitric cycle 
 
 
 
1.1.5 Activity of the mmg Operon and the Methylcitric Cycle 
The methylcitric cycle is interconnected with the citric acid cycle.  The 
methylcitric cycle is encoded in the latter half of the mmg operon.  These genes include 
mmgD, mmgE, and mmgF with additional help from CitB, an aconitase enzyme.  In our 
previous work, MmgD was shown to condense propionyl-CoA and oxaloacetate to form 
one of the “heterochiral” enantiomers (2S, 3R) or (2R, 3S)- 2-methylcitrate.  MmgE then 
acts as a dehydratase to produce 2-methylaconitate 10.  Another enzyme, CitB then 
hydrates 2-methylaconitate to produce 2-methylisocitrate 11.  Once 2-methylisocitrate is 
formed, MmgF then acts as a methylisocitrate lyase to form pyruvate 12 and succinate 
13.12  Pyruvate can then undergo further transformation to be converted into acetyl-CoA 
needed for the citric acid cycle, and succinate can then reenter the citric acid cycle as an 
 
Figure 2. β-Oxidation of ω-3 Fatty Acid Acyl-CoA’s.  In B. subtilis approximately 
85 % of fatty acids are methylated at the omega-3 position.  During β-oxidation the 
result should be the production of acetyl-CoA and propionyl-CoA. 
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intermediate.  The enzyme activity of MmgDEF and CitB is shown in figure 3 along with 
the interconnections of the citric acid cycle. 
 
 
 
 
 
Figure 3. The Interconnection of the Methylcitric Acid Cycle and Citric Acid 
Cycle Involving the Degradation of Propionyl-CoA.  The interconnection of the 
methylcitric cycle and the citric acid cycle is encoded in the mmg operon.  Here the 
enzymes MmgDE and YqiQ (MmgF) are responsible for the observed 
transformations.  CitB is an aconitase enzyme that hydrates the olefin 10.  The 
methylcitric acid cycle is activated when β-oxidation produces propionyl-CoA.  At the 
end of the methylcitric acid cycle succinate and pyruvate are produced.  Succinate 
will continue into the citric acid cycle and pyruvate will undergo further 
transformation. 
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1.2 Literature Review of Methylcitrate Lyase 
1.2.1  Previous Methylcitric Lyase Results Obtained from B. subtilis 
Evidence of the methylcitric acid cycle in B. subtilis has been previously shown 
by the Reddick lab.  Each step was studied individually using available substrate, except 
MmgF.  The only way to obtain 2-methylisocitrate was to reconstruct the enzymatic 
pathway sing MmgD, MmgE, CitB and MmgF.  The activity was determined with a 
single enzymatic reaction by incubating MmgDEF and CitB, with propionyl CoA and 
oxaloacetate yielding pyruvate and succinate.12  The methylcitric acid cycle has also been 
studied in other bacterial species such as Escherichia coli and Salmonella enterica 
through their homologous gene operons, prp.15   
In the final step of the methylcitric acid cycle 2-methylisocitrate is cleaved to 
form pyruvate and succinate by MmgF.12  However, it is unclear which stereoisomer is 
utilized by the enzyme.  It has been reported that the enzyme from Escherichia coli PrpB 
uses (2R, 3S)-2-methylisocitrate.16  PrpB and MmgF are homologous proteins with 42 % 
sequence identity and 61 % sequence similarity.   
1.2.2  Previous Published Syntheses of 2-Methylisocitrate 
In an effort to determine the preferred stereoisomer of the MmgF substrate in B. 
subtilis, 2-methylisocitrate must be synthesized because it is not commercially available.  
There are published syntheses of 2-methylisocitrate,16, 17 but they have been problematic 
to reproduce in our lab (William Booth MS thesis and Nicolas Coffey MS thesis).  The 
goal of this Master’s project is to finish the synthesis of 2-methylisocitrate by modifying 
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the published syntheses.  Upon completion of the syntheses, the desired products will be 
used to determine the activity of MmgF. 
In the first published synthesis by Brock et al.,16 the description of the synthesis 
led to a lack of reproducibility in our lab.  Important details from the syntheses were 
lacking such as freshly distilled chemicals were required for dry conditions.  Some of the 
terminology used in the step were incorrect or crude products were carried forward in the 
synthesis.  The combined effects led to reproducibility problems in our lab.  The 
published reaction sequence from Brock et al. is presented Scheme 1.  
 
 
 
The first step of the synthesis utilized a sodium tungstate dihydrate catalyst to 
produce an epoxide disodium salt, was then acidified.  The work-up for the acidification 
step stated that an extraction of the residue was performed, but this terminology was 
incorrect.  The concentrated residue was actually triturated to isolate the desired product.  
Scheme 1.  Original Reaction Sequence Starting with Citraconic Anhydride16 
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The third step in the synthesis utilized thionyl chloride and anhydrous methanol to obtain 
the dimethyl ester.  This step presented problems because both of the required reagents 
needed to be completely anhydrous and freshly distilled.  The literature never stated that 
anhydrous conditions and freshly distilled reagents were needed for this step.  The next 
reaction with sodium methoxide, dimethyl malonate, and the dimethyl ester, produced a 
tetrahydrofuran ring which was then treated with 6 M HCl to deprotect the methyl esters 
and reveal the free acids.  After deprotection, the methyl ester that is closest to the 
carbonyl group on the tetrahydrofuran ring also underwent decarboxylation under the 
same reaction conditions.16  In this published synthesis the procedure for the final step 
(the hydrolysis of the lactone ring) to produce the 2-methylisocitric acid was not reported. 
 
 
 
The second procedure that was followed was published by Munoz-Elias et al.17 
and is depicted in Scheme 2.  Although the paper claimed to improve upon the chemistry 
described by Brock et al.,16 this paper still presented us with issues of reproducibility.  
The sequence of reactions is shown in scheme 2.  The synthesis was identical to the 
Scheme 2.  Reaction Sequence for the Mesaconic Pathway from Literature17 
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above procedure, but the first step with the sodium tungstate dihydrate catalyst was 
problematic for us to repeat.  Thionyl chloride was also used in the revised published 
synthesis for the esterification, followed by the deprotection and decarboxylation of the 
methyl ester at room temperature for 3 hours.  The final step in the synthesis involved a 
ring opening to produce the desired 2-methylisocitrate.  Our improvements and 
clarifications to this synthesis will be indicated in the preliminary work section. 
 Both Coffey and Booth were only able to get to 17 with success, but were unable 
attempt the completion of the pathway. 
1.3 Literature Review of Methylcitrate Synthase 
1.3.1  Previous 2-Methylcitrate Synthase Work 
In previous studies by Brock et al.,15 the stereochemistry of the intermediates of 
the methylcitric cycle from E. coli were investigated.  They reported that the 
“homochiral” (2S, 3S)-2-methylcitrate was produced by PrpC and this product was 
isomerized to (2R, 3S)-2-methylisocitrate by the enzymes methylcitrate dehydratase 
(PrpD) and aconitase (AcnB), respectively.15  This isomerization would require a syn 
elimination followed by an anti addition of water across the double bond.  Our laboratory 
has observed results that conflict with these literature reports.  Our lab has shown that 
MmgD from B. subtilis and PrpC from E. coli produce one of the heterochiral 
enantiomers ((2S, 3R) or (2R, 3S)) of 2-methylcitrate and has also shown evidence that 
MmgE and PrpD use only the anti elimination mechanism to produce (Z)-2-
methylaconitate 27 from either of the heterochiral 2-methylcitrate enantiomers, or (E)-2-
11 
methylaconitate 28 from either of the homochiral 2-methylcitrate enantiomers.  The 
dehydration and addition of water across the double bond can be seen in Figure 4. 
 
 
 
The assignments of the stereochemistry by Brock et. al.15 were based on 
comparisons that were reported in previous journal articles.  This might be faulty when 
trying to determine the absolute stereochemistry of the product, because no structural 
elucidation was performed in any of these studies.   
 
Figure 4. Dehydration of Heterochiral and Homochiral 2-Methylcitrate.  
Possible dehydration results of the homochiral and heterochiral 2-methylcitrate 
via the trans elimination of water has been observed in previous studies.  Here 
both the heterochiral and homochiral diastereomers are represented with their 
appropriate eliminations.  With the trans elimination of the heterochiral 
enantiomers the Z-alkene will be produced and the homochiral enantiomers 
will afford the E-enantiomers. 
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In a more recent paper by Krawczyk and Martyniuk,18 the NMR data of the 
homochiral and the heterochiral 2-methylcitrate were reported.  In order to make these 
assignments they used two synthetic organic methods to produce different diastereomers.  
In their reported synthesis they took advantage of enolate chemistry and the selectivity 
associated with the different types of reagents.  The first method utilized zinc as a 
chelating metal to obtain a racemic mixture of the homochiral enantiomers.  The second 
method produced the heterochiral enantiomers with lithium diisopropylamide.   
 
 
The different stereoisomers can be determined by considering the transition states 
in the mechanism and the different types of control.  Since zinc is a chelating metal the 
Reetz-Cram chelating metal model19 should be used, and depicted in Figure 5.  With this 
model, 1,3-asymmetric induction occurs by minimizing the steric hindrance between the 
1,3-carbonyl-containing compound and the organozinc reagent leading to a Reformatsky 
reaction and ultimately the homochiral enantiomers.  The lithium diisopropylamide 
 
 
Figure 5. Cram Chelating Metal Transition State Model.  Cram chelating metel 
transition state model is used to control the stereochemistry with the Reformatsky 
reaction.  Since the nucleophile attacks from the least sterically hindered side of the 
electrophile this leads to the homochiral set of enantiomers 
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reaction is stereochemically controlled with the Zimmerman-Traxler model20 as seen in 
Figure 6.  The transition state minimizes 1,3-diaxial clashing in the chair conformation, 
which eventually leads to the heterochiral enantiomers.   
 
 
 
The information presented by Krawcyzk et al.18 and the analysis of the transition 
state models led our lab to conduct further analysis of the enzymatic products from 
MmgD and PrpC by HPLC and compare the enzymatic results to NMR experiments of 
the commercial standard.  When MmgD and PrpC were separately incubated with 
propionyl-CoA and oxaloatate it was observed that they produced the same substance 
which co-eluted with the minor product from the commercially available standard as seen 
in Figure 7. 
 
 
 
 
Figure 6. Zimmerman-Traxler Transition State Model.  Zimmerman-Traxler 
transition state with the use of Lithium diisopropylamide leads to the heterochiral set 
of enantiomers by reducing the steric hindrance of the 1,3-diaxial interactions.  
14 
 
 
Through personal communications with Sigma-Aldrich it was disclosed that the 
standard was synthesized through the Reformatsky reaction.  Considering the transition 
state models the major component of the reaction would have the stereochemistry of 
(2RS, 3RS)-2-methylcitrate and the minor product would take on the (2RS, 3SR)-2-
methylcitrate stereochemistry. 
The commercial standard was further analyzed by NMR correlared with the 
results obtained by Krawczyk et al.18  According to their NMR results the C2-methyl 
peak from the homochiral set of enantiomers would be further downfield from the 
heterochiral enantiomers.18  Our NMR analysis of the commercial standard showed the 
major product peaks shifted further down field seen in Figure 8.  Utilizing the disclosed 
reaction conditions from Sigma-Aldrich, it was determined that the major component of 
the standard was the (2RS, 3RS) enantiomers.  These results were consistent with 
Krawcyzk’s data.  The ratio of the major to minor product is 9 to 1.  According to the 
 
Figure 7. Comparison of Enzymatic Products from MmgD and PrpC with 
the Commercial Standard.  When comparing the enzymatic products from 
MmgD and PrpC from B. subtilis and E. coli, respectively, they line up with the 
minor product from the commercially available standard from Sigma-Aldrich.  
The enzymatic reactions are shown in line A and the commercial standards are 
in line B of both chromatograms obtained from HPLC analysis.  
Bacillus subtilis
(MmgD)
Escherichia coli
(PrpC)
Commercial Standard
Commercial Standard
Enzymatic Reaction
Enzymatic Reaction
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Krawczyk et al.18 the products from the Reformatsky reaction would have a methyl group 
located on carbon-2 with a multiplicity of a double at 1.07 ppm and the other` 
stereochemical outcome from this reaction would be (2RS, 3RS)-2-methylcitrate.  The 
doublet at 0.97 ppm belongs to the heterochiral enantiomers (2RS, 3SR)-2-methylcirtate. 
 
 
 
Based on this NMR data and our HPLC analysis with the enzymatic reactions 
compared to the commercial standard, we have concluded that the product produced by 
MmgD and PrpC is one of the heterochiral enantiomers and not (2S, 3S)-2-methylcitrate 
as stated by Brock et al.17  The HPLC analysis with stereochemical analysis is shown in 
 
Figure 8. NMR Analysis of the Commercially Available 2-Methylcitrate.  
The NMR analysis of the commercially available standard from Sigma-
Aldrich synthesized through the Reformatsky reaction shown two different 
sets enantiomers were produced.  The major component at 1.07 ppm is the 
homochiral enantiomers and the minor product would be the heterochiral 
enantiomers.  The ratio of major to minor products is 9 to 1. 
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Figure 9.  The integrated ratios of the major or minor products is 9 to 1 like the NMR 
analysis. 
 
 
 
1.3.2  Plan to Synthesize Enantiopure 2-Methylcitrate  
In order to determine the absolute stereochemistry of 2-methylcitrate formed by 
MmgD (and PrpC from E. coli), the four diastereomers will be synthesized in an 
enantioselective manner.  Many reactions in organic synthesis produce a racemic mixture 
of desired products.  This arises from the reagents and the starting material reacting in a 
non-selective manner.  Many molecules can interact from two sides.  This occurs most 
often when the reaction happens at a planar functionality such as an alkene.  Depending 
on the type of reaction a trans or syn-addition will be observed.  Reactions such as 
halogenation or any reaction that involves the formation of a bromonium ion, add across 
 
Figure 9. HPLC Stereochemical Comparison of the Enzymatic Reaction with 
the Commercial Standard of 2-Methylcitrate.  With the results from the NMR 
analysis the product peaks from the commercial standard were assigned.  The 
minor commercial product which lines up with the results from the enzymatic 
reactions can be assigned as the heterochiral ((2RS, 3SR)-2-methylcitrate) 
enantiomers.  The integrated values of the peaks are 1 to 9, minor to major. 
(2RS, 3RS)(2RS, 3SR)
Bacillus subtilis
(MmgD)
Escherichia coli
(PrpC)
Commercial Standard
Commercial Standard
Enzymatic Reaction
Enzymatic Reaction
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the double bond in an anti-manner.  The initial step in the formation of the bromonium 
ion is syn addition, but the following step is anti-addition.  Epoxidations, hydroboration 
oxidation, and hydrogenations via Pd/C and the Lindlar catalyst, interact with the planar 
functionality in a syn-fashion.  This allows for the stereochemistry of the product to be 
predicted but not controlled, thus producing two enantiomers as a racemic mixture.  If a 
carbocation is formed during the reaction the stereochemical outcome will be a mixture 
of diastereomers. 
The desire to control the stereochemical outcome of a reaction was driven by the 
pharmaceutical industry.  One of the best known examples for the need of enantiopure 
medications is Thalidomide.  In the mid 1950’s racemic Thalidomide was prescribed to 
pregnant women to help control morning sickness.  The women that took Thalidomide 
began to give birth to babies with birth defects.  It was later determined that only one of 
the enantiomers of Thalidomide showed teratogenic effects.21   
Enantioselective synthesis was led by three chemists, William Knowles, K. Barry 
Sharpless, and Ryoji Noyori.  Their research revolved around alkenes and adding 
substituents to a desired face of the functional group.  In 2001 these three chemists were 
awarded a Nobel prize for the use of metal catalysts in asymmetric synthesis.  Sharpless 
developed catalysts for asymmetric epoxidations,22 dihydroxylations,23 and 
oxyaminations.24  Noyori and Knowles worked on enantioselective cyclopropanations25 
and asymmetric hydrogenation,26 respectively. 
The stereochemical outcome of a reaction can be controlled by many different 
methods.  Some methods include, but are not limited to, chiral catalysts, steric hindrance, 
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the formation of solvent cage effects, and addition of chiral axillary groups, biocatalysts, 
chiral resolution, enantioselective organometallic catalysts, and functional groups that act 
as coordinating groups.  
Epoxides are useful organic synthesis tools when an alcohol group must be added 
to a double bond along with another functional group.  This is due to the control that can 
be obtained when the epoxide is opened under acidic or basic conditions.  When the 
epoxide is open under acidic conditions the most sterically hindered side will be attacked 
because of the formation of a carbocation at that position.  Under alkaline conditions the 
epoxide will be attacked on the less sterically hindered side.  The traditional methods of 
forming epoxides are not enantioselective and will lead to a racemic mixture of products 
being obtained.  If an enantiopure alcohol is needed these methods are not acceptable and 
the need for asymmetric epoxidations arises. 
In order to determine the absolute stereochemistry of 2-methylcitrate synthase, an 
asymmetric epoxidation will be utilized to set the two stereocenters.  There are several 
modern organic chemistry methods that have the ability to form asymmetric epoxides, 
and they all work best with different types of alkenes.  The Sharpless asymmetric 
epoxidation requires an allylic alcohol to be present in the substrate.27  The Jacobsen-
Katsuki asymmetric epoxidation works best with cis-olefins, but is a poor candidate for 
epoxidation to trans-olefins and tri-substituted olefins due to the steric hindrance of the 
salen catalyst.28  More recently, R. Curci and co-workers reported the ability of 
dioxiranes to produce epoxides on a variety of substrates.29  Dioxirane can be produced in 
situ from a ketone and an oxidant.  Wanting to harness the ability of dioxirane, Y. Shi and 
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co-workers developed a highly selective method of epoxidation utilizing fructose 
derivatives as chiral catalysts.30-33  The Shi epoxidation method is able to form 
enantioenriched products on a wide variety of olefins.   
When the chiral ketone catalyst was being developed, it was determined that the 
best candidate would contain chiral centers in close proximity to the reactive ketone, have 
a rigid, fused ring structure, and possess a bulky structural component that would only 
allow access to the dioxirane from one direction.  With these elements in mind 
carbohydrates were the chosen starting material for the catalyst design.  Ultimately, D-
fructose was chosen as the building block for the catalyst, because it is readily available, 
inexpensive, and possesses several chiral centers with known configurations.  It was also 
important that the catalyst contain multiple oxygen atoms to increase the reactivity of the 
ketone through induction.  In 1996, Y. Shi and co-workers developed a fructose derived 
ketone catalyst that successfully formed epoxides on trans and tri-substituted olefins.30  
 
 
Figure 10. The Original Shi Ligand and Its Derivatives.  The original Shi ligand 
ligand 29 was developed from D-fructose due to the chiral centers already present in 
the molecule, but it was not effective at epoxidizing cis or α,β-unsaturated olefins.  
Derivative 30 is effective epoxidizing cis olefins and 31 harnesses the ability to form 
an epoxide on α,β-unsaturated esters.   
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The original Shi ligand 29 derived from D-fructose only possessed the ability to 
form an epoxide on trans or tri-substituted olefins.30-32  Other types of olefins were 
determined to be poor substrates for the original ligand.30  In an effort to resolve this 
issue, two similar chiral ketone ligands were developed.  These derivatives are shown in 
Figure 10.    
The first derivative 30 that was developed possessed the ability to form an 
asymmetric epoxide on cis olefins.  This catalyst was modified at the 1,3-oxirane spiro 
cycle moiety to include a carbamate where the nitrogen is protected by a Boc group.33    
The epoxidation of electron poor olefins such as α,β-unsaturated esters have been 
troublesome for traditional methods.  It is possible to use a nucleophilic epoxidizing 
agent such as hydrogen peroxide treated with sodium hydroxide, but this method is not 
stereoselective.  To overcome this obstacle Shi and coworkers developed a derivative of 
their original catalyst by removing the ketal moiety and replacing it with two acetate 
groups 31.  This increased the electrophilicity of the dioxirane ring formed and enabled 
the epoxidation of α,β-unsaturated esters.34  
The Shi epoxidation is not without its faults.  The reaction conditions must be 
strictly regulated to produce the desired results.  The pH of the reaction has been shown 
to affect the reaction profoundly.35  The optimum pH for the Shi epoxidation is 
approximately 10.5.  If the epoxidation is conducted at a lower pH, the Shi catalyst will 
undergo a Baeyer-Villiger oxidation when it interacts with Oxone.34, 35 The Baeyer-
Villiger reaction pathway will eventually lead to hydrolysis and produce acetone 
subsequently leading to a competing reaction.  The acetone produced through hydrolysis 
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would interact with Oxone producing dimethyldioxirane in situ that would have to ability 
to form an epoxide with the olefin.29 The product from this reaction would not be 
enantioenriched.  This would cause a decreased enantiomeric excess due to the structural 
simplicity of dimethyldioxirane produced.29 
 
 
 
If the reaction is conducted at a higher pH, Oxone will undergo auto 
decomposition.35  The pH of the reaction can be controlled with the addition of potassium 
carbonate or the reaction can be carried out in an EDTA solution buffered to the desired 
pH.35  The auto decomposition of Oxone can also be reduced by decreasing the 
 
Figure 11. The Shi Catalytic Cycle.  The D-fructose derived Shi ligand does not 
possess the ability itself to form an epoxide upon an olefin.  Oxone acts as an 
oxidant on the ketone of D-fructose to form a dioxirane ring which is then the 
epoxidizing agent of the Shi ligand.  If the pH is not strictly controlled a Baeyer-
Villiger oxidation will occur and the ligand will be degraded to acetone.   The 
acetone can then react with oxone and lead to a non-stereoselective epoxidation. 
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temperature of the reaction to 0 °C.  The catalytic cycle and possible side reactions are 
shown in Figure 11. 
When the Shi ligand is used as an epoxidizing agent the stereochemistry of the 
products can be predicted by considering the sterics between the catalyst and the 
substrate.  It has been shown that the Shi ligands prefer a spiro transition state compared 
to the planar transition state.30  The spiro transition state is produced when the dioxirane 
is orthogonal to the olefin, and the planar transition states would occur when the 
dioxirane is parallel to the olefin.  Figure 12 depicts a simplified version of possible 
transition states with trans olefins. 
 
 
Figure 12. Possible Transition States of the Shi Ligand.  After the dioxirane ring 
has been formed on the Shi ligand there are four possible transition states, but they can 
be broken down into two types, spiro and planar.  The spiro transition state occurs 
when the olefin is orthogonal to the dioxirane ring and the planar forms when the 
olefin is parallel to the ring.  The favored transition state happens when steric 
hindrance is minimalized.  The favored spiro transition state produces the (R,R) 
configuration with a simple trans olefin. 
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An asymmetric epoxidation was chosen to set the stereocenters of 2-methylcitrate, 
because of the chiral alcohol present on carbon 3.  The available starting materials for the 
synthesis of enantiopure 2-methylcitrate by this method are E-aconitic and and Z-aconitic 
acid.  By undergoing a Fischer esterification trimethyl E-aconitate and Z-aconitate will be 
obtained.  These compounds are then candidates for the Shi asymmetric epoxidation for 
α,β-unsaturated esters.  Once the epoxide is obtained a Grignard reaction will be used to 
install the methyl group at carbon 2, then the free acids can be revealed by deprotection 
of the esters.  The general linear synthesis is presented in Scheme 3. 
 
 
 
Scheme 3.  Proposed Synthesis of Enantiopure 2-Methylcitrate 
 
Scheme 4.  Reaction Sequence to Obtain (2S, 3S)-2-Methylcitrate.  
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With the modified commercial Shi ligand only two of the four diastereomers of 2-
methylcitrate will be obtained, (2S, 3S)-2-methylcirate and (2R, 3S)-2-methylcirate.  The 
synthetic plan for these diastereomers is shown in Schemes 4 and 5, respectively.  
The predicted stereochemistry of the epoxide products 36 and 41 was obtained through 
transition state models where the favored spiro transition state reduced the steric 
hindrance of the Shi ligand and the substrate for the epoxidation.  The transition state 
model to produce 36 is seen in Figure 13 and the transition state model for 41 is depicted 
in Figure 14. 
 
 
 
In order to obtain the (2R, 3R)-2-methylcitrate and (2S, 3R)-2-methylcitrate 
diastereomers the enantiomer of the commercially available Shi ligand must be 
synthesized through total synthesis, then modified to include the acetyl groups instead of 
the bicyclic ketal moiety. 
 
 
 
 
Scheme 5.  Reaction Sequence to Obtain (2R, 3S)-2-Methylcitrate.  
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Figure 13. Transition States with Trimethyl E-Aconitate.  The transition state 
models with trimethyl E-aconitate and the modified Shi ligand for α,β-unsaturated 
ester was used to determine the stereochemical out and the epoxide produced during 
the reaction. 
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1.4 Central Hypothesis and Objectives 
Bacillus subtilis is a model organism and the entire genome has been sequenced.1  
However, there is an incomplete understanding of the metabolic pathways that are 
encoded within the genome.  A long-term goal of the Reddick research group is to gain a 
more complete understanding of the mmg operon.  The overall objective of this thesis is 
to develop the syntheses of 2-methylisocitrate and 2-methylcitrate.  The central 
 
Figure 14. Transition States with Trimethyl Z-Aconitate.  The transition state 
models were utilized to determine the stereochemical outcome of the epoxide product 
with trimethyl Z-aconitate and the Shi ligand for α,β-unsaturated esters.  
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hypotheses of these objectives are that MmgF cleaves one of the enantiomers of 2-
methylcitrate to produce succinate and pyruvate, and MmgD 2-methylcitrate synthase 
produces the heterochiral ((2S-3R) or (2R,3S))-2-methylcitrate.  The proposed syntheses 
will allow new investigations furthering the understanding of the mother cell metabolic 
(mmg) operon.  Previous graduate students either were unable to finish the synthesis of 2-
methylisocitrate or experienced reproducibility problems with this synthesis.  Progress 
towards the long-term goal of the Reddick research group and the accomplishment of this 
Master’s project’s overall objective will be realized through specific objectives. 
1.4.1 2-Methylisocitrate Lyase Objective  
To develop the syntheses of (2RS, 3RS) and (2RS, 3SR)-2-methylisocitrate using 
modified literature methods for the purpose of determining the substrate of the MmgF 
enzyme of B. subtilis.  In this specific objective we will utilize synthetic organic 
chemistry to prepare racemic (2RS, 3RS) and (2RS, 3SR)-2-methylisocitrate.  The 
synthetic products will be used to determine the stereochemical preferences of MmgF in 
future studies. 
1.4.2 2-Methylcitrate Synthase Objective 
To develop a stereoselective synthesis of all four stereoisomers ((2R, 3S), (2S, 
3R), (2R, 3R) and (2S, 3S)) of 2-methylcitrate in an enantiopure fashion.  The Shi 
asymmetric epoxidation specific for α,β-unsaturated esters will be utilized to achieve an 
enantiopure epoxide product.  The four stereoisomers of 2-methylcitrate made from 
enantiopure epoxides will be used as standards of the products of MmgD (methylcitrate 
synthase).  This will ultimately allow the unambiguous assignment of the stereoisomers 
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produced by 2-methylcitrate synthases from various species, and will help settle 
ambiguities between our work with the B. subtilis and E. coli systems and those that were 
reported in the literature. 
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CHAPTER II 
EXPERIMENTAL 
2.1  Syntheses of (2RS, 3RS)-2-Methylisocitric Acid  
2.1.1  Cis-epoxymethylsuccinate Disodium Salt 15 
 
 
 
Citraconic anhydride 14 (9.56g, 1 eq) was suspended in water (30 mL) at an 
ambient temperature and the temperature of the mixture was decreased to 0 ℃.  Sodium 
hydroxide (5.07 g, 1.49 eq) was dissolved in water (7.5 mL) then added slowly to the 
cooled citraconic anhydride suspension.  Sodium tungstate (0.8517 g, 0.05 eq) dihydrate 
was added to the reaction followed by the dropwise addition of 33% hydrogen peroxide 
(10 mL, 1.03 eq).  The temperature of the reaction was monitored and maintained at 65 
℃ first by cooling then by heating.  The reaction was stirred for 3 hours before it was 
concentrated to half volume by reduced pressure.  The desired compound was 
recrystallized with acetone (12.59 g, 87 % yield). 1H NMR (D2O, 500 MHz) ẟ 1.36 (s, 
3H) 3.22 (s, 1H).   
Scheme 6. Reaction Conditions to Obtain 15 
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2.1.2 Cis-epoxymethylsuccinic Acid 16 
 
 
 
The disodium salt 15 (11.11 g, 1 eq) was dissolved in 300 mL of diethyl ether and 
5 mL water.  Concentrated sulfuric acid (6 mL, 1.72 eq) was dissolved in 70 mL of 
diethyl ether then added to the reaction and allowed to stir at room temperature overnight.  
The solvent was removed with reduced pressure and three triturations were performed on 
the resulting residue with diethyl ether (3 x 20 mL).  The combined extracts were dried 
over anhydrous magnesium sulfate then the solvent was removed with reduced pressure 
(7.94 g, 83 % yield) 1H NMR (D2O, 500 MHz) ẟ 1.43 (s, 3H) 3.57 (s, 1H). 
 
 
 
 
 
 
Scheme 7.  Reaction Conditions to Obtain 16 
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2.1.3 Dimethyl cis-epoxymethylsuccinate 17 
 
 
 
Cis-epoxymethylsuccinic acid 16 (5.05 g, 1 eq) was dissolved in 22 mL of freshly 
distilled methanol (from Mg/I2) at room temperature under an argon environment.  
Concentrated sulfuric acid (0.277 mL, 0.15 eq) was dissolved in dry methanol then added 
to the reaction.  The reaction was allowed to stir for three days at ambient temperature 
then the solvent was removed with reduced pressure.  The resulting oil was taken up into 
diethyl ether (70 mL) and washed once with 1 M sodium sulfate (20 mL).  The organic 
layer was dried with anhydrous sodium sulfate followed by solvent evaporation with 
reduced pressure.  The crude oil was further purified with flash chromatography over 
silica gel with 20 % ethyl acetate in hexanes as the eluent (3.54 g, 59 % yield). 1H NMR 
(CDCl3, 500 MHz) ẟ 1.61 (s, 3H), 3.46 (s, 1H), 3.74 (s, 3H), and 3.74 (s, 3H). 
 
 
 
 
 
 
Scheme 8.  Reaction Conditions to Obtain 17 
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2.1.4 Trimethyl 2-methyl-5-oxotetrahydrofuran-2,3,4-tricarboxylate 18 
 
 
 
Dry methanol (10 mL) was reacted with sodium metal (0.27 g, 1 eq) at 0 °C.  
Distilled dimethyl malonate (1.7 mL, 1.3 eq) was added to the reaction at once. When a 
significant amount of white precipitate was observed dimethyl cis-epoxymethylsuccinate 
17 (2.05 g, 1 eq) was added, and the mixture became yellow.  The reaction was allowed 
to stir at room temperature for four days under argon atmosphere.  Concentrated HCl (5 
mL) was added and stirred for an additional hour and a half.  The sodium chloride 
precipitate was removed by vacuum filtration.  The solvent from the filtrate was removed 
under reduced pressure, then the crude oil was dissolved in diethyl ether.  The organic 
layer was washed with water, then the aqueous layer was extracted two times with ether.  
The combined organic layers were dried with anhydrous magnesium sulfate.  The desired 
product was purified with 30 % ethyl acetate in hexanes.  (0.65 g, 20 % yield)  1H NMR 
(CDCl3, 500 MHz) ẟ 1.48 (s, 3H), 3.72 (s, 3H), 3.75 (s, 3H), 3.76 (s, 3H), 4.04 (d, 1H), 
and 4.14 (d, 1H).  13C NMR (CDCl3, 125 MHz) δ 14.2, 32,0, 40.7, 49.3 52.7, 53.3, 53.7, 
165.3, 168.5, 169.7, 170.6. 
 
Scheme 9.  Reaction Conditions to Obtain 18 
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2.1.5 Erythro 2-methylisocitrate Lactone 19 
 
 
 
The purified trimethyl 2-methyl-5-oxotetrahydrofuran-2,3,4-tricarboxylate 18 
(0.11 g) was heated at reflux for four days with 6 M HCl (6 mL).  The solvent was 
removed by reduced pressure then trace amounts of HCl were removed by evaporation 
with water three times.  The brown and green residue was dissolved in water and treated 
with activated charcoal for thirty minutes at 60 ̊C.  After removal of the carbon by 
vacuum filtration, the water was removed from the filtrate with reduced pressure.  
(0.0204 g, 27 % yield)  
 
 
 
 
 
 
 
 
Scheme 10. Reaction Conditions to Obtain 19 
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2.1.6 (2SR, 3SR)-2-methylisocitrate 20 
 
 
 
 
The erythro 2-methylisocitrate lactone 19 (0.05 g, 1 eq) was treated with water 
(0.331 mL) and sodium hydroxide (0.33 g) at 80 ℃ for 16 hours.  The pH was 
neutralized with 0.1 M HCl then the solvent was removed with reduced pressure.  The 
obtained solid was dissolved in water and treated with activated charcoal at 60 ℃.  The 
mixture was filtered and the filtrate was retained and frozen.  [M-H]- = 205 m/z 
 
 
 
 
 
 
 
 
 
 
Scheme 11.  Reaction Conditions to Obtain 20 
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2.2  Synthesis of (2RS, 3RS)-2-Methylisocitrate 
2.2.1 Trans-epoxymethylsuccinic Acid 22 
 
 
 
Mesaconic acid  21 (0.55 g, 1 eq) was suspended in nanopure water then treated 
with sodium hydroxide (0.30 g, 1.8 eq) at room temperature.  Once a clear solution was 
observed the temperature of the reaction was decreased to 0 ℃ over a period of one hour.  
Sodium tungstate dihydrate (0.05 g, 0.04 eq) was added to the cooled reaction, followed 
by the dropwise addition of hydrogen peroxide (0.48 mL).  After the dropwise addition of 
hydrogen peroxide was completed, the pH was immediately monitored with pH paper 
and adjusted to a pH of 5.5 using 6 M sodium hydroxide.   The reaction was allowed to 
stir for one hour at 0 ℃ while the pH of the reaction was monitored and readjusted to pH 
5.5.  After an hour the reaction was allowed to warm to room temperature, then increased 
to 70 ℃, and stirred overnight at that temperature under a water-cooled condenser.  After 
the overnight heating, the solvent was removed with reduced pressure.  The obtained 
white solid was mixed with 5 mL ethyl acetate, 5 mL diethyl ether, and 0.5 mL water.  
The reaction was acidified with concentrated sulfuric acid (0.4 mL) dissolved in 3.5 mL 
Scheme 12.  Reaction Conditions to Obtain 22 
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of diethyl ether, and allowed to stir for 2.5 hours.  The organic layer was separated and 
dried with anhydrous sodium sulfate.  The solvent was removed with reduced pressure 
and a white solid 22 was obtained (0.4955 g, 79 % yield).  1H NMR (D2O, 400 MHz) ẟ 
1.33 (s, 3H) 3.70 (s, 1H).  13C NMR (D2O, 100 MHz) ẟ 12.3, 58.5, 170.5, and 172,7. 
2.2.2 Dimethyl trans-epoxymethylsuccinate 23 
 
 
 
The previously synthesized trans-epoxymethylsuccinic acid 22 (0.51 g) was 
dissolved in 2.2 mL anhydrous methanol under an argon environment.  Sulfuric acid 0.13 
M in methanol (1.5 mL) was added and allowed to stir at room temperature for 3 days.  
The solvent was removed with reduced pressure then the oil was dissolved in diethyl 
ether.  The organic layer was washed with 1 M sodium sulfate and dried over anhydrous 
sodium sulfate.  The compound was purified over silica gel with 20 % ethyl acetate and 
hexanes.  The solvent was evaporated with reduced pressure, then trace solvents were 
removed with high vacuum.  A clear oil was obtained.  (0.301 g, 51 % yield)  1H NMR 
(CDCl3, 400 MHz) ẟ 1.54 (s, 3H), 3.72 (s, 3H), 3.76 (s, 3H) and 3.76 (s, 1H).  
13C 
(CDCl3, 100 MHz) ẟ 14.1, 52.9, 52.5, 56.9, 166.7, 169.1. 
 
 
Scheme 13.  Reaction Conditions to Obtain 23 
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2.2.3 2-methyl-5-oxo-2,3,4-tricarbomethoxytetrahyrofuran 24 
 
 
 
Anhydrous methanol (1.25 mL) at 0 ℃ was reacted completely with sodium 
metal (0.039 g, 1.2 eq.).  The solution was allowed to return to room temperature and 
freshly distilled dimethyl malonate (0.25 mL, 1.6 eq) was added to the sodium 
methoxide.  The reaction was allowed to stir until a white precipitate formed then the 
dimethyl ester 23 (0.243 g, 1 eq.) obtained from the previous step was added.  The 
reaction was allowed to stir for five days.  Concentrated hydrochloric acid (1 mL) was 
added to quench the reaction.  Sodium chloride formed and was filtered off then the 
filtrate was concentrated to produce the crude product.  A clean NMR spectrum has not 
yet been obtained to confirm the desired product 24 has been produced.  Efforts to purify 
the compound have been made, but the mixture of compounds is co-eluting.  The 
published literature syntheses did not purify the desired product.  The crude material was 
carried forward in the next reaction.  (0.38 g, 67 % yield)  [M+H]= 275.0757 m/z 
 
 
 
Scheme 14.  Reaction Conditions to Obtain 24 
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2.2.4 2-methyl-5-oxo-2,3-tricarbotetrahydrofuran 25 
 
 
 
The crude produce 24 (0.2202 g, 1eq) was refluxed in 6 M HCl (4.5 mL) for 4 
days followed by the removal of solvent by reduced pressure.  The concentrated reaction 
was dissolved three time in 20 mL of water and evaporated each times to removes 
residual HCl.  The brown oil was dissolved in 20 mL of water and treated with activated 
charcoal for 30 minutes at 80 °C.  The reaction was filtered through a 1 cm bed of celite 
to remove the charcoal.  The solvent was removed with reduced pressure. 
2.3  Other Epoxidation Methods 
2.3.1 Dimethyl Mesaconate 44 
 
 
 
Mesaconic acid 21 (0.1008 g) was dissolved in 1 mL of dry methanol, then 0.9 
mL of 0.13 M sulfuric acid in methanol was added.  The reaction refluxed for 18 hours 
Scheme 15.  Reaction Conditions to Obtain 25 
 
Scheme 16.  Reaction Conditions to Obtain 44 
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under argon, then the solvent was removed with reduced pressure.  The pale yellow oil 
was dissolved in diethyl ether and washed with 1 M sodium sulfate.  The organic layer 
was dried over anhydrous sodium sulfate followed by the removal of solvent by reduced 
pressure.  The desired compound was purified over silica gel with 10 % ethyl acetate in 
hexanes.  (0.053 g, 43 % yield)  1H NMR (CDCl3, 400 MHz) ẟ 2.11 (s, 3H), 3.59 (s, 3H), 
3.63 (s, 3H), and 6.59 (s, 1H).  13C NMR (CDCl3. 100 MHz) δ 13.9, 51.4, 52.3, 126.2, 
165.9, and 167.2. 
2.3.2 Dimethyl trans-epoxymethylsuccinate 23 Conditions B 
 
 
 
meta-Chloroperoxybenzoic acid (0.9548 g) was dissolved in dichloromethane 
(12.5 mL).  Dimethyl mesaconate 44 (0.59 g) was added, and the reaction was refluxed 
for 24 hours.  The solvent was removed with reduced pressure and the white solid was 
dissolved in saturated sodium carbonate and extracted 2 times with diethyl ether (30 mL).  
The solvent was again removed with reduced pressure and the product was purified over 
silica gel with 10 % ethyl acetate and hexanes.  The desired product was not obtained. 
 
 
 
Scheme 17.  Reaction Conditions to Obtain 23 from 44 with DCM 
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2.3.3 Dimethyl trans-epoxymethylsuccinate 23 Conditions C 
 
 
 
meta-Chloroperoxybenzoic acid (0.15 g) was dissolved in 1 mL of 
tetrahydrofuran.  To the reaction dimethyl mesaconate 44 (0.17 g) was added and 
refluxed for 24 hours.  The solvent was removed with reduced pressure and the white 
solid was dissolved in saturated sodium carbonate and extracted with diethyl ether (2 x 15 
mL).  The solvent was again removed with reduced pressure and purified over silica gel 
with 10 % ethyl acetate and hexanes.  The desired product was not obtained.  
2.3.4 Dimethyl trans-epoxymethylsuccinate 23 Conditions D 
 
 
 
meta-Chloroperoxybenzoic acid (0.4923 g) was dissolved in dichloromethane (4.4 
mL) and reacted with sodium hydroxide (0.1374 g).  To the reaction dimethyl 
mesaconate (0.21 g) was added and refluxed for 24 hours.  The solvent was removed with 
reduced pressure followed and the obtained white solid dissolved in saturated sodium 
Scheme 18.  Reactions Conditions to Obtain 23 from 44 with THF 
 
Scheme 19.  Reaction Conditions to Obtain 23 with a Nucleophilic Epoxidation 
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carbonate and extracted 3 times with diethyl ether (25 mL).  The solvent was again 
removed with reduced pressure and purified over silica gel with 5 % ethyl acetate and 
hexanes.  The desired product was not obtained. 
2.3.5 Trans-epoxymethylsuccinic Acid 22 with Oxone 
 
 
 
Mesaconic acid 21 (0.1597 g, 1 eq) was dissolved in dichloromethane (5 mL) then 
tetrabutylammonium hydrogen sulfate (0.1595 g, 3.8 eq.) and acetone (0.5 mL, 5.5 eq) 
were added followed by the addition of saturated sodium bicarbonate (8.3 mL).  The 
reaction temperature was reduced to 0 ° C.  Oxone (1.4653 g, 7.8 eq) was dissolved in 6 
mL of water then slowly added to the reaction over 15 minutes then allowed to stir for an 
additional two hours.  The reaction was allowed to stir for another 18 hours at room 
temperature.  The solvent was removed with reduced pressure.  The solid was dissolved 
in diethyl ether (5 mL), ethyl acetate (5 mL), and water (0.5 mL).  Sulfuric acid (0.4 mL) 
was dissolved in 3.5 mL of diethyl ether then added to the reaction.  The reaction stirred 
was at room temperature for two hours.  The organic layer was separated and dried over 
anhydrous magnesium sulfate.  The solvent was removed with reduced pressure.  1H 
Scheme 20.  Reaction Conditions to Obtain 22 with Curci’s Method 
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NMR (D2O, 400 MHz) δ 1.36 and 3.70.  
13C NMR (D2O, 100 MHz) δ 12.3, 54.5, 170.5, 
and 172.7. 
2.4  Modification of the Shi Catalyst for Asymmetric Epoxidations 
2.4.1 Shi Catalyst Diol 32 with Acetic Acid 
 
 
 
A solution of acetic acid (80 mL) and water (20 mL) was added at once to the Shi 
diketal catalyst 29 (0.06 g).  The reaction was allowed to stir for 24 hours at room 
temperature followed by the removal of the solvent at room temperature.  The crude 
mixture was dissolved in methylene chloride (30 mL), dried with anhydrous magnesium 
sulfate, and filtered.  The filtrate was then evaporated to afford a white solid.  1H NMR 
(CDCl3, 400MHz) ẟ 1.33(s, 3H), 1.53 (s, 3H), 3.28 (m, 0.3 H), 3.97 (DD, J = 12, 4 Hz, 
1H), 3.99 (d, J = 8 Hz, 1H), 4.32 (d, J = 12 Hz, 1H), 4.39 (m, 1H), 4.67 (d, J = 12 Hz, 
1H), and 4.72 (d, J = 4 Hz, 1H) 13C (CDCl3, 100 MHz) ẟ 26.24, 26.39, 63.32, 69.59, 
73.61, 74.20, 104.36, 133.64, and 199.03. 
 
 
 
Scheme 21.  Reaction Conditions to Obtain 32 with Acetic Acid 
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2.4.2 Shi Catalyst Diol 32 with DDQ 
 
 
 
The Shi diketal catalyst 29 (0.0674 g) was dissolved in acetonitrile (0.81 mL) and 
water (0.09 mL) then DDQ was added.  The reaction was allowed to stir for nine hours at 
room temperature.  The reaction was concentrated with reduced pressure at room 
temperature.  The thick red oil was then dissolved in ethyl acetate and dried with 
anhydrous sodium sulfate, filtered, and the solvent was removed with reduced pressure.  
The crude product was purified with flash chromatography of silica gel with 10 % 
methanol in methylene chloride.  The desired product was not obtained according to the 
NMR results. 
 
 
 
 
 
 
 
Scheme 22.  Reaction Conditions to Obtain 32 with DDQ 
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2.5  Synthesis of Substrates for Asymmetric Epoxidation 
2.5.1 Trimethyl-E-2-methylaconitate 40 
 
 
 
E-aconitic acid 39 (0.7 g, 1 eq.) was dissolved in anhydrous methanol (5 mL) then 
sulfuric acid (0.05 mL) as added.  The reaction was refluxed under argon for 23 hours.  
The solvent was removed by reduced pressure then dissolved in water and extracted with 
ethyl acetate (20 mL) three times.  The combined organic layers were washed with brine 
and dried over anhydrous sodium sulfate.  The solvent was removed with reduced 
pressure and purified over silica gel with 30 % ethyl acetate and petroleum ether.  (0.026 
g, 3 % yield)  1H NMR (CDCl3, 400 MHz) δ 3.53 (s, 3H), 3.61 (s, 3H), 3.66 (s, 3H), 3.80 
(s, 2H), and 6.78 (s, 1H).  13C NMR (CDCl3, 100 MHz) ẟ 32.7, 51.9, 52.0, 52.7, 128.8, 
139.8, 165.6, 166.2, 170.1. 
 
Scheme 23.  Reaction Conditions to Obtain 40 
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CHAPTER III  
RESULTS AND DISCUSSION 
3.1  Analysis of ((2RS, 3RS) and (2RS, 3SR))-2-Methylisocitrate 
3.1.1  Analysis of (2RS, 3RS)-2-Methylisocitrate 
 
 
 
The published literature procedures by Brock et al. had to be modified greatly in 
order for the reactions to be reproducible for our lab.  The esterification required two 
reagents to be distilled prior to the reaction.  A previous graduate student decided to 
utilize a Fischer esterification36 instead because only methanol would need to be distilled.  
The lactonization was altered by increasing the equivalents of sodium metal used to
Scheme 24.  Modified Literature Procedures for the Citraconic Anhydride Pathway 
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deprotonate the dimethyl malonate.  In the procedure by Brock et al. it was stated that 1 
equivalent of sodium was used, but in the procedure only 0.1 equivalents were reported.  
The second to last step was altered by increasing the reaction time from three days to 
four.  The final step of the synthesis was not published even though 2-methylisocitrate 
was used in the enzymology section of the paper.  Another paper was consulted to 
synthesize the desired product; however, the procedure was altered to include 0.1 M HCl 
instead of Amberlite and the pH was decreased to 4 instead of 7.  This change was made 
because the pKa values of carboxylic acid are approximately 4.5.  Scheme 25 outlines the 
reactions conditions used to obtain (2RS, 3RS)-2-methylisocitrate. 
The final product was analyzed with mass spectrometry.  The calculated mass of 
the neutral (2RS. 3RS)-2-methylisocitrate is 206.0427 amu.  The mass spectrum analysis 
was ran in negative mode therefore the mass of a proton must be subtracted, bringing the 
mass to 205.0354 amu.  The observed mass from the analysis was 205.04 amu.  This is 
within the acceptable limits, therefore the desired product was synthesized.   
Figure 15 shows the base peak chromatogram obtained from mass spectrometry 
analysis.  In the chromatogram two 205.04 amu peaks were observed.  This was due to 
the epimerization of one of the stereocenters due to all the acid/base chemistry used in the 
synthesis.  The major product peak is the (2RS, 3RS)-2-methylisocitrate set of 
enantiomers, the minor peak is the (2RS, 3SR)-2-methylisocitrate enantiomers.   
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3.1.2  Analysis of the (2RS, 3SR)-2-Methylisocitrate 
 The stated reaction conditions from the published synthesis required great 
modifications in order to obtained the desired intermediates in the synthesis of (2RS, 
3SR)-2-methylisocirate.  The first reaction in the linear synthesis was a tungstate 
epoxidation.  The epoxide is an important intermediate, because it will eventually become 
the alcohol group on carbon 3.  If the reaction was conducted with the stated conditions 
from the literature reference the desired epoxide was not obtained, therefore many steps 
were taken to make the epoxidation more reliable.  The modifications were attempted as 
outlined below. 
First, the procedure was modified by removing the three hour stir at room 
temperature with ethyl acetate, diethyl ether, water and concentrated sulfuric acid 
dissolved in diethyl ether.  Instead the reaction was lowered to a pH of 2 with 0.1 M HCl 
 
 
Figure 15. Base Peak Chromatogram of (2SR, 3SR)-2-Methylisocitrate.  The base 
peak chromatogram obtained from mass spectrometry analysis shows two products 
with the same weight were obtained.  The major product are the (2RS, 3RS)-2-
methylisocitrate enantiomers, the minor peak obtained due to epimerization are the 
(2RS, 3SR)-2-methylisocitrate. 
+ ent.
48 
to try and extract the epoxy product into the organic layer.  The desired product was not 
obtained. 
The second modification of the original procedure involved increasing the 
equivalents of the base to three to deprotonate both carboxylic acid groups and the 
hydrogen peroxide.  The desired product was not obtained. 
The third modification increasing the equivalents of the hydrogen peroxide to 
both two and three equivalents.  The equivalents of the sodium tungstate catalyst and the 
hydrogen peroxide were also adjusted to determine if more catalyst or oxidant were 
needed to push the reaction forward via le Chatelier’s principle.  The desired product was 
not obtained. 
Next the starting material was recrystallized to insure that no contaminants were 
stopping the epoxidations from occurring.  The desired product was not obtained. 
Then pH of the reaction was monitored to ensure that it stayed around pH 5.5.37  
The pH was changed at different time intervals including immediately after the hydrogen 
peroxide was added, and other time intervals such as 5, 10, and 30 minutes.  The pH was 
also changed after the one hour cold stir of the mesaconic acid, sodium hydroxide, 
hydrogen peroxide, and the tungstate catalyst was completed, and immediately before the 
reaction was increased to 70 ℃.  The desired product was obtained only when the pH 
was changed as soon as the hydrogen peroxide was added.   
 Once the tungstate and hydrogen peroxides are introduced to the reaction the pH 
would drop between 4 and 4.5.  At such low pH’s the tungstate catalyst tends to take on a 
polymeric form;37 however, when the pH is increased to 5.5 the catalyst spreads 
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homologously throughout the reaction.37  This allows the catalyst to take on the bidentate 
form with the substrate and the epoxidation will occur.   
 The final product in the linear synthesis has not been obtained yet, but the 
intermediate 24 has been confirmed by mass spectrometry analysis, this was due to the 
inability of the intermediate to be identified by NMR.  The obtained NMR spectrum 
contained several unexpected peaks due to the inability to purify the desired compound 
and the presence of eight stereoisomers consisting of four major diastereomers and four 
minor diastereomers.  This is due to the diastereomers obtained from the opening of the 
epoxide with dimethyl malonate.  The epoxide is opened on the least sterically hindered 
side.  The opening of the epoxide allows for rotation around the 3C and 4C bond.  Even 
though there are eight stereoisomers present in the reaction, the amount of stereoisomers 
will be reduced in the next step due to the loss of the temporary stereocenter.   
 
 
Figure 16. Base Peak Chromatogram of 2-methyl-5-oxo-2,3,4-
tricarbomethoxytetrahydofuran.  The base peak chromatogram obtained from mass 
spectrum analysis shows two product peaks.  This is due to three stereocenters formed 
during the reaction.  There is due to diastereomer formation and 8 stereoisomers being 
present.  
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The exact mass of 2-methyl-5-oxo-2,3,4-tricarbomethoxytetrahyrofuran is 
274.0767 amu.  Since the analysis was run in positive mode the weight of a proton must 
be added to the molar mass bringing the calculated mass to 275.0767 amu.  The observed 
mass was 275.0757 amu which has a mass error of 3.6 ppm.  The acceptable mass error is 
5 ppm, therefore the lactone was synthesized.  Figure 16 shows the base peak 
chromatogram obtained from mass spectrometry analysis.  The obtained spectrum shows 
two 275.0757 amu peaks  The linear reaction sequence with modified literature 
conditions is shown in Scheme 25. 
 
 
 
3.1.3  Other Epoxidation Methods 
In an effort to side step the tungstate epoxidation to form trans-2-methylisocitrate 
22 other methods were explored such as mCPBA with various solvents and the addition 
of a base, but the epoxide was never formed.  Another method tried utilized the dioxirane 
ring formed with Oxone and acetone.  The desired epoxide was obtained with this 
Scheme 25.  Modified Literature Procedures for the Mesaconic Pathway 
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method, but the trans-epoxy acid was unable to be separated from the starting material as 
seen in Figure 17.  The methyl group of the starting material appears at 1.99 ppm and a 
vinyl proton is observed at 6.63 ppm.  The trans-epoxy acid peak appear at 1.39 and 3.74 
ppm.  Integration of the peaks indicated there was approximately 60 % conversion of the 
starting material to the desired epoxide. 
 
 
 
3.2  Enantiopure Synthesis of 2-Methylcitrate 
3.2.1 Modification of the Shi Ligand 
 The modification to the commercially available Shi chiral ketone ligand has 
proven to be more difficult than expected.  The vicinal diol 32 is unstable; therefore, the 
purification of 32 has not been successful.  When the solvent was removed with reduced 
pressure and heated the molecule degrades and vinyl protons are present in the NMR 
 
Figure 17. 1H NMR Analysis of Oxone Reaction.  The obtained 1H NMR (D2O, 400 
MHz) shows both starting material and the desired epoxide present.  The mesaconic 
acid peaks appear at 3.63 and 1.99 ppm.  Trans-epoxymethylsuccinic acid peak are 
located at 1.39 and 3.74 ppm. 
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spectrum even though there are no vinyl protons present in 32.  Also if flash column 
chromatography was used for purification the desired product 32 would degrade.   
 
 
 
In an effort to reduce the acidity of the silica gel used in the purification process 
the column was pretreated with triethylamine.  However, the desired product was still not 
obtained.  Triethylamine was then included in the eluent during purification, but the silica 
gel still degraded 32.To confirm the presence of the vicinal diol 32 NMR analysis of the 
crude product was performed.  The 1H NMR in Figure 18 shows the desired product 
peaks.  The chemical shifts and calculated J-coupling constants correspond to the 
 
Figure 18. 1H NMR of Modified Shi Ligand.  The Shi ligand was analyzed with 1H 
NMR.  When compared to the reference peaks and J-coupling constants it was 
determined that the desired product was synthesized. 
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reported literature values.  To further confirm the desired product 13C NMR was obtained 
as seen in Figure 19. 
 
 
 
3.2.2  Analysis of Substrate for Asymmetric Epoxidation 
The substrate for the Shi asymmetric epoxidation was synthesized with a 3 % 
yield due to the volatility of the trimethyl E-aconitate.  During the evaporation of the 
solvent the compound was put under reduced pressure which decreased the boiling point 
of the solvent and the desired product.  Due to the decreased boiling point the compound 
was removed along with the solvent.  This can be overcome by using a heavier protecting 
 
Figure 19. 13C NMR of Modified Shi Ligand.  The 13C NMR was used to insure all 
the carbons were intact since the proton NMR was not clean due to an inability to 
purify the compound. 
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group for the carboxylic acids.  Tert-butyl or benzyl group could be used instead of the 
methyl esters. 
 
 
 
The desired product was confirmed with NMR analysis shown in the Figure 20.  
The 1H NMR showed three methyl esters at 3.53, 3.61, and 3.66 ppm, a vinyl proton at 
6.78 ppm, and a methylene group 3.80 ppm.  The protons of the methylene group are 
shifted downfield due to the electron withdrawing groups on either side leading to the de-
shielding of the protons.  Acetone is present in the spectrum at 2.01 ppm due to residual 
solvent used to clean the flash column chromatography fraction tubes. 
 
 
 
Figure 20. 1H NMR of Trimethyl E-Aconitate.  1H NMR was conducted to confirm 
the presence of the desired compound.  The product peaks are observed at 3.53, 3.61, 
3.66, 3.80, and 6.78 ppm. 
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3.3  Conclusion 
 Both of the projects presented here involved organic synthesis of substrates for 
the enzymatic study of MmgD and MmgF.  The published literature procedures presented 
many issues that needed to be solved.  Through a systematic problem-solving approach 
the linear syntheses of (2RS, 3RS)-2-methylisocitrate was successfully completed.  The 
synthesis of (2RS, 3SR)-2-methylisocitrate required many modifications especially with 
the tungstate epoxidation.  The linear syntheses presented in this work can be replicated 
successfully and will lead to the production of the desired products.   
 The synthesis of enantiopure 2-methylcitrate has been designed utilizing the 
asymmetric Shi epoxidation to set the stereocenters.  Future work on this project should 
include the completion of the needed modification for the Shi ligand to successfully form 
an epoxide on an α,β-unsaturated ester, followed by the total synthesis of the enantiomer 
of the Shi ligand for α,β-unsaturated esters.  With these Shi ligands all four diastereomers 
of 2-methylcitrate can be obtained, then used as standards to compare to the enzymatic 
product of MmgD. 
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